Yale to lead trial of potential COVID-19 treatment
Yale School of Medicine and the biopharmaceutical firm AI Therapeutics have launched a multi-institutional clinical trial of a drug for treating COVID-19.
Related Articles
Sadhguru Quotes – Fear and ignorance are always together. Clarity of Knowing releases one from fear.
Fear and ignorance are always together. Clarity of Knowing releases one from fear.
San Francisco 49ers
The official source for San Francisco 49ers news, schedules, stats, scores and more.
Headline: NFL+ | Live Games on mobile, NFL RedZone, NFL Network and More!
NFL+ is the National Football League’s exclusive streaming service. NFL+ exists within the NFL app and NFL.com ecosystem and delivers a combination of live local…
WSJ News Exclusive | Russia and China Sent Large Naval Patrol Near Alaska
Four U.S. destroyers were dispatched to monitor Russian and Chinese ships in the area.
FDA approves second Yale-researched treatment for alopecia areata
Yale dermatologist Dr. Brett King has now earned FDA approval for two new medicines for alopecia areata in 13 months.
Eliminating extra chromosomes in cancer cells prevents tumor growth
Many cancer cells have too many chromosomes. A new study reveals their role in promoting cancer — and their potential as a new target for…
Harnessing the power of healthy cells to suppress skin cancer formation
Skin injuries promote healthy-cell expansion, impeding the growth of mutated cells, a new study finds. The discovery could inform treatments for skin cancer.
Juneteenth: Remembering the day slavery ended in the U.S.
The Yale campus will be closed in observance of Juneteenth, but a series of local events will offer opportunities to celebrate and reflect.
San Francisco Homeowners Lose $260 Billion In Value
US residential home values have declined modestly since their 2022 peak, reflecting higher mortgage interest rates.
Meet me at the intersection
For Saybrook’s Jenny Tan, soon to be an investment banker, the convergence of domains was a theme that emerged at Yale.
